New York University Medical Center SC-3

New York, New York 10016

0 studies enrolling now · 1 studies all time

What they study most

Tuberous Sclerosis Complex-associated Refractory Seizures

Studies at this site

• A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures — Completed